Table 1.
Demographic and biochemical characteristics of the T2DM patients and control subjects
| Variables | Controlsa (n = 138) | T2DM patientsa (n = 150) | P |
|---|---|---|---|
| Age (y) | 59.12 ± 10.4b | 61.32 ± 13.6b | 0.12 |
| Sex (Male/Female) | 74/64 | 87/63 | 0.45 |
| BMI (kg/m2) | 27.45 (25.6‐28.96) | 27.4 (25.07‐28.9) | 0.35 |
| LDL (mg/dL) | 94.5 (85‐110) | 103.5 (84.3‐115) | 0.03 |
| HDL (mg/dL) | 42 (39‐47) | 41.5 (38‐46) | 0.12 |
| TG (mg/dL) | 153.94 ± 25.37b | 162.54 ± 33.01b | 0.01 |
| Total cholesterol (mg/dL) | 160 (145‐178) | 160 (143‐186) | 0.47 |
| Fasting blood sugar (mg/dL) | 90 (85.75‐97) | 138 (126.75‐153.25) | 0.000 |
| HbA1c (%) | 4.44 (3.66‐4.96) | 7.92 (7.22‐9.4) | 0.000 |
| Insulin (μ IU/mL) | 5.34 (4.36‐7.12) | 9.32 (8.35‐9.81) | 0.000 |
| HOMA‐IR | 1.14 (0.95‐1.52) | 3.35 (2.87‐4.05) | 0.000 |
BMI, Body Mass Index; HbA1c, glycated hemoglobin; HDL‐C, high‐density lipoprotein cholesterol; HOMA, homeostasis model assessment of insulin resistance; LDL‐C, low‐density lipoprotein cholesterol; TG, Triglycerides.
a
Data are presented as median (interquartile range).
b
Result is presented as mean±SD.